Trial Profile
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Sep 2014
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Research & Development